About Us

Innovators. Dreamers. Industry Leaders.

Eutilogics, Inc. is a collection of people who are committed to improve health and well-being around the world.  The core technology that Eutilogics employs for drug development is selecting targets that faithfully enhance or suppress human immune responses.

​

Our core technology is to employ human peripheral T lymphocytes as a therapeutic.  We also have a series of immunomodulatory antibody therapeutics that are being developed to treat obesity and autoimmune diseases.  Both T cell and antibody therapies are expected to produce powerful therapeutic activities with no or minimal toxicity.